Association of vitamin D receptor gene polymorphisms
with rheumatoid arthritis
More details
Hide details
1
Pharmacy Service, Pharmacogenetics Unit, University Hospital Virgen de las Nieves,
UGC Provincial de Farmacia de Granada, Granada, Spain
2
Department of Social Pharmacy, Faculty of Pharmacy, University of Lisbon, Lisbon,
Portugal
3
Department of Biochemistry, Faculty of Pharmacy, University of Granada, Granada,
Spain
4
Clinical Analysis Service, Hospital Campus de la Salud, Granada, Spain
5
Department of Physical Chemistry, Faculty of Pharmacy, University of Granada,
Granada, Spain
Submission date: 2019-07-02
Final revision date: 2020-01-14
Acceptance date: 2020-01-14
Online publication date: 2021-03-22
Corresponding author
Cristina Perez Ramirez
Department of Social Pharmacy
Faculty of Pharmacy
University of Lisbon
Av. Prof. Gama Pinto
1600-083 Lisbon, Lisboa e Vale do Tejo-Portugal
Telephone: +351217946400
Arch Med Sci 2024;20(5)
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease of unknown etiology which causes progressive deterioration
of the joints, leading to severe pain and functional disability. Vitamin D and
its receptor (VDR) play a significant part in the onset of autoimmune diseases such as RA. The purpose of this study was to evaluate the association
between VDR gene polymorphisms and risk of developing RA.
Material and methods:
A retrospective study was performed, including
214 RA cases and 748 controls of Caucasian origin. FokI (rs2228570), BsmI
(rs1544410), TaqI (rs731236), ApaI (rs7975232) and Cdx2 (rs11568820) gene
polymorphisms were analyzed by TaqMan
Results:
The recessive logistic regression model showed that the VDR FokIAA genotype was associated with lower risk of RA (p = 0.0255; OR = 0.58;
95% CI: 0.35–0.92). No other genetic polymorphism showed any association with RA in any of the models tested. Haplotype analysis revealed that
the haplotypes ACGAG (p = 0.033; OR = 1.62; 95% CI: 1.04–2.53) and GTGCA
(p < 0.01; OR = 2.77; 95% CI: 1.53–4.98) for BsmI, Cdx2, FokI, ApaI and TaqI
were associated with higher risk of RA.
Conclusions:
VDR FokI gene polymorphism showed a trend for risk of RA,
taking into account the variables of gender, age and tobacco use, and preventing false positives. Among our patients we found no influence of VDR
BsmI, TaqI, ApaI and Cdx2 on the risk of developing RA. However, haplotype
analysis indicated that the haplotypes ACGAG and GTGCA were associated
with higher risk of RA.